WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'7801 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 13'0461 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 48'229  47'791  47'342  46'881  46'406  40'404  34'272  27'738 
Births 747  754  761  768  776  848  905  881 
Surviving infants 734  741  747  755  762  829  877  837 
Pop. less than 5 years 3'738  3'770  3'796  3'826  3'868  4'152  4'341  3'986 
Pop. less than 15 years 11'713  11'805  11'882  11'951  12'027  12'740  12'465  11'262 
Female 15-49 years 13'204  13'147  13'084  13'012  12'922  11'207  9'018  6'780 

Number of reported cases

(Click for retrospective incidence data for Colombia)
Diphtheria
ChartChart
  11  16 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  12'520  9'222 
Mumps
ChartChart
  6'573  7'368  7'884  9'377  15'926 
Pertussis
ChartChart
  986  734  13'682  3'289  1'010  446  1'961  7'664 
Polio*
ChartChart
  129 
Rubella
ChartChart
  157 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10  133 
Tetanus (total)**
ChartChart
  48  59  31  50  37  27  167  593 
Yellow fever
ChartChart
  11 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Colombia)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS   83  90  89  85  89  83  91  95  45 
DTP1 2009  97  DHS   83  93  91  89  91  84  75 
DTP3 2009  90  DHS   83  91  90  91  91  85  79  88  16 
DTP4          93  90 
IPV1          92 
HepB_BD          87  86  82  85  85  82 
HepB3 2009  90  DHS   83  91  90  91  92  85  78 
Hib3 2009  90  DHS   83  91  90  91  91  85  65 
JapEnc         
MCV1          94  91  92  94  88  80  82  13 
MCV2          86  88  72  79  76  84 
PCV1          93  91  89  94  81 
PCV3          91  89  87  84  46 
Pol3 2009  82  DHS   83  91  90  91  91  85  82  93  16 
Rota1          90  89  86  88  80 
RotaC          91  89  87  87  78 
Rubella1          94  91  92  94  88 
TT2plus 1994  57  DHS   47  51  33  33  42  80 
PAB         
VAD1         
YFV 2009  77  DHS   83  54  92  92  92  88 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Colombia)
BCG
ChartChart
  90  89  85  89  83  91  95  45 
DTP1
ChartChart
  93  91  97  91  95  91  96  39 
DTP3
ChartChart
  91  90  91  91  85  79  88  16 
HepB3
ChartChart
  91  90  91  92  85  78 
HepB_BD
ChartChart
  87  86  82  85  85  82 
Hib3
ChartChart
  91  90  91  91  85  65 
IPV1
ChartChart
  92 
MCV1
ChartChart
  94  91  92  94  88  88  82  13 
MCV2
ChartChart
  86  88  72  80  76  84 
PAB
ChartChart
  85  85  79  79  79  70  45 
PCV3
ChartChart
  91  89  87  84  46 
Pol3
ChartChart
  91  90  91  91  85  82  93  16 
RCV1
ChartChart
  94  91  92  94  88  88 
RotaC
ChartChart
  91  89  87  87  78 
YFV
ChartChart
  92  92  92  92  88 

Number of districts in the country 1'122  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 50
From 80 to 89% 25
From 50 to 79% 24
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9-17 years; +6 months; Yes
HepA 1 year; Yes
HepB_Adult 1st contact; +1, +6 months; No Risk groups
HepB_Pediatric birth; Yes
IPV 2 months; Yes
Influenza_Adult Yes pregnant women, adults with chronic diseases, health care workers and other risk groups
Influenza_Pediatric 6-12, 12-23, 24-47 months; Yes and children with chronic diseases
MMR 1, 5 years; Yes
MR 10-39 years; Yes
OPV 2, 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rabies Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months;+1, +1 years; Yes For CBAW in risk areas and pregnant women
Tdap Pregnant women from week 24
Varicella 1 year; Yes
YF 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2014  2014-2019  2010-2014    2011-2014  2007-2010  2008-2011 
Nº of districts with microplans that include activities to raise immunization coverage number     80  1'123  1'123  1'119  1'119 

System performance

Total Nº districts in country number 1'122  1'122  1'122  1'123  1'123  1'123  1'120 
Nº districts with DTP3 coverage >=80% number 733  710  853  474  551  645  640 
% of districts with DTP3 coverage >=80% From 0 to 100% 65  63  76  42  49  57  57 
Nº districts with measles (MCV1) coverage >=95% number 310  393  480  288  277  434  377 
% of districts with MCV1 coverage >=95% From 0 to 100% 28  35  43  26  25  39  34 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.